Funds and prices
Overview
Regulation / Supervision: UCITS III / CSSF (funds for institutional investors)
Authorised investors: pension funds, insurance companies, family offices and institutional investors under CISA
Investments: Equity securities issued by European companies listed in the MSCI Europe ex UK ex Switzerland Index
Convertible and warrant bonds: none
Portfolio is passively managed and aims to replicate the performance of the benchmark
Currency exposure: in line with securities portfolio
Securities lending: not permitted
Use of derivatives: permitted under BVV2
Risks
All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.
Features
| Product category |
Equity
Global |
| Product domicile |
Luxembourg
|
| Portfolio management |
蜜豆视频 Asset Management Switzerland AG, Zurich
|
| Fund management |
蜜豆视频 Fund Management (Luxembourg) S.A., Luxembourg
|
| Custodian bank |
蜜豆视频 Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
蜜豆视频 Fund Management (Switzerland) AG
|
| Day of inception |
May 13, 2020
|
| Currency of account |
CHF
|
| Close of financial year |
December 31
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Flat fee |
0.00% p.a.
|
| Management fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.01% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe ex UK ex Switzerland (net div. reinv.) in CHF
|
| Cut-Off Time |
15:00h (CET)
|
| Securities no. |
52215770
|
| ISIN |
LU2108968301
|
| Bloomberg Ticker |
UEPIIXA LX
|
Performance and Prices
Percentage growth
as of April 3, 2024
Cumulative
| CHF(%) | EUR(%) | USD(%) | |
| YTD | 15.93 | 9.94 | 7.71 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 12.72 | 19.72 | 23.91 |
| 3Y | 15.47 | 30.66 | 20.24 |
| 5Y | |||
| ø p.a.5Y | 4.91 | 9.32 | 6.34 |
Current data
| Net asset value | 03.04.2024 | CHF 1,633.79 |
| High - last 12 months | 27.03.2024 | CHF 1,638.23 |
| Low - last 12 months | 20.10.2023 | CHF 1,269.81 |
| Assets of the unit class in mn | 03.04.2024 | CHF 716.74 |
| Total product assets in mn | 03.04.2024 | CHF 2,510.24 |
Statistical data
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 29.02.2024 | 18.10% | n.a. |
| Sharpe Ratio | 29.02.2024 | 0.31 | n.a. |
| Risk Free Rate | 31.03.2024 | 0.87% | -0.06% |
Structures
By the 10 largest equity positions (in %, as of February 29, 2024)
|
|
|
| Novo Nordisk A/S | 5.71 |
| ASML Holding NV | 5.58 |
| LVMH Moet Hennessy Louis Vuitton SE | 3.71 |
| SAP SE | 2.87 |
| Siemens AG | 2.22 |
| TotalEnergies SE | 2.14 |
| Schneider Electric SE | 1.82 |
| L'Oreal SA | 1.69 |
| Allianz SE | 1.61 |
| Sanofi SA | 1.59 |
Fees
Portfolio management fees
0.0000%
Admin/Custodian fees, max.
0.0000%
Distributions
No distributions. Continuous reinvestment of income.
Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
| Statutes / Management regulations |
|
|
||
| ASIP ESG Report |
|
|
|
Annual and semi-annual report (accounting on December 31)
|
Document type
|
Document Language
|
||
| Annual report |
|
|
|
| Semi-annual report |
|
|
|
